e-Edition
Obituaries
Special Sections
Special Occasions
Contact
Subscribe
Paywall Login
Login to Comment
Register
December 11th, 2017
jobs
homes
Menu
Home
News
Sports
Business
Entertainment
Classifieds
Commentary
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Heartbeam, Inc. - Common Stock
(NQ:
BEAT
)
1.120
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Mar 24, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Heartbeam, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Heartbeam Inc. (NASDAQ: BEAT) Partners with Mount Sinai to Accelerate AI-ECG Development and Validation
March 24, 2026
Via
Investor Brand Network
Topics
Artificial Intelligence
HeartBeam Inc. (NASDAQ: BEAT) Featured in Coverage of the 38th Annual ROTH Conference
March 16, 2026
Via
Investor Brand Network
Topics
Intellectual Property
AINewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Reports Q4 and Full-Year 2025 Results, Advances Commercialization and Clinical Development
March 13, 2026
Via
Investor Brand Network
Topics
Intellectual Property
HeartBeam Reports Fourth Quarter and Full Year 2025 Results
March 12, 2026
From
HeartBeam, Inc.
Via
Business Wire
BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Collaborates With Mount Sinai to Advance AI-ECG Algorithm Development
March 10, 2026
Via
Investor Brand Network
Topics
Artificial Intelligence
Intellectual Property
HeartBeam and Mount Sinai Announce Strategic AI Collaboration to Bring Clinical-Grade Heart Monitoring into the Home
March 10, 2026
From
HeartBeam, Inc.
Via
Business Wire
HeartBeam Inc. (NASDAQ: BEAT) Moves Forward Focused on Advancing Portable, High-Fidelity Cardiac Monitoring
March 09, 2026
Via
Investor Brand Network
Topics
Artificial Intelligence
BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Management to Participate in March 2026 Investor and Industry Conferences
March 09, 2026
Via
Investor Brand Network
Topics
Intellectual Property
HeartBeam to Attend Investor and Industry Conferences in March, Focused on Providing Updates on Commercial Launch and Unveiling 12-Lead ECG Extended Wear Patch
March 09, 2026
From
HeartBeam, Inc.
Via
Business Wire
BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Enrolls First Patients in ALIGN-ACS Pilot Study for Heart Attack Detection
March 05, 2026
Via
Investor Brand Network
Topics
Intellectual Property
BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Schedules March 12 Conference Call to Review Q4 and Full-Year 2025 Results
March 05, 2026
Via
Investor Brand Network
Topics
Intellectual Property
HeartBeam Announces First Patient Enrollments in Heart Attack Detection Pilot Study
March 05, 2026
From
HeartBeam, Inc.
Via
Business Wire
HeartBeam to Host Fourth Quarter Full Year 2025 Results Conference Call on Thursday, March 12, 2026 at 4:30 p.m. Eastern Time
March 04, 2026
From
HeartBeam, Inc.
Via
Business Wire
AINewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Announces Commercial Partnership With ClearCardio as First Customer and Strategic Investor
March 04, 2026
Via
Investor Brand Network
Topics
Intellectual Property
HeartBeam Announces First Commercial Customer as ClearCardio Brings Groundbreaking 12-Lead ECG Technology to High-Growth Preventive Cardiology Market
March 04, 2026
From
HeartBeam, Inc.
Via
Business Wire
HeartBeam Inc. (NASDAQ: BEAT) Upgraded to Buy as New Joseph Gunnar Report Raises Price Target on Commercialization Momentum
March 03, 2026
Via
Investor Brand Network
NetworkNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Showcased for Advancing Innovative ECG Platform
February 19, 2026
Via
Investor Brand Network
Topics
Intellectual Property
HeartBeam Inc. (NASDAQ: BEAT) Highlighted Among Medical Device Innovators as FDA Clearances Set Tone for New Year
February 12, 2026
Via
Investor Brand Network
Topics
Artificial Intelligence
BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Appoints Bryan Humbarger as Chief Commercial Officer
January 22, 2026
Via
Investor Brand Network
HeartBeam Appoints Bryan Humbarger as Chief Commercial Officer
January 22, 2026
From
HeartBeam, Inc.
Via
Business Wire
BioMedNewsBreaks – FDA Clearance for HeartBeam Inc. (NASDAQ: BEAT) Highlighted in Medical Device Approvals Roundup
January 09, 2026
Via
Investor Brand Network
Topics
Intellectual Property
NetworkNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) to Attend JP Morgan 2026 Annual Healthcare Conference
January 05, 2026
Via
Investor Brand Network
Topics
Intellectual Property
HeartBeam to Attend JP Morgan 2026 Annual Healthcare Conference
January 05, 2026
From
HeartBeam, Inc.
Via
Business Wire
AINewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Ranks Second Worldwide in 12-Lead ECG Innovation
December 17, 2025
Via
Investor Brand Network
Topics
Artificial Intelligence
Intellectual Property
Game-Changing News: BEAT, APRE, TOON, MNTS, PRSO, PNPNF, SIGL – Stocks Under $1 Look Now
December 10, 2025
Via
AB Newswire
InvestorNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Secures FDA 510(k) Clearance for 12-Lead ECG Synthesis Software Following Successful Appeal
December 10, 2025
Via
Investor Brand Network
Topics
Intellectual Property
HeartBeam Receives FDA Clearance for First-Ever, Cable-Free Synthesized 12-Lead ECG for At-Home Arrhythmia Assessment
December 10, 2025
From
HeartBeam, Inc.
Via
Business Wire
BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Outlines Regulatory Strategy After NSE Decision on ECG Synthesis Software
December 01, 2025
Via
Investor Brand Network
Topics
Intellectual Property
HeartBeam Provides Update on Regulatory Path Following FDA Decision on 12-Lead ECG Synthesis Software Application
November 26, 2025
From
HeartBeam, Inc.
Via
Business Wire
InvestorNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Poised in the Future of Cardiac Care with Breakthrough Technology
November 19, 2025
Via
Investor Brand Network
Topics
Intellectual Property
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.